| Literature DB >> 23391744 |
Marcus Kernt1, Sarah Cserhati, Florian Seidensticker, Raffael Liegl, Anselm Kampik, Aljoscha Neubauer, Michael W Ulbig, Lukas Reznicek.
Abstract
This study indicates that in addition to the significant improvement in visual acuity and reduction of central retinal thickness in patients with center-involving diabetic macular edema, intravitreal anti-VEGF treatment with Ranibizumab may also lead to a significant stabilization or even improvement of diabetic retinopathy.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23391744 DOI: 10.1016/j.diabres.2013.01.006
Source DB: PubMed Journal: Diabetes Res Clin Pract ISSN: 0168-8227 Impact factor: 5.602